283 related articles for article (PubMed ID: 21472711)
1. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
Samadder NJ; Mukherjee B; Huang SC; Ahn J; Rennert HS; Greenson JK; Rennert G; Gruber SB
Cancer; 2011 Apr; 117(8):1640-8. PubMed ID: 21472711
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
3. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
4. Mesalamine protects against colorectal cancer in inflammatory bowel disease.
Tang J; Sharif O; Pai C; Silverman AL
Dig Dis Sci; 2010 Jun; 55(6):1696-703. PubMed ID: 19705280
[TBL] [Abstract][Full Text] [Related]
5. Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
Ananthakrishnan AN; Cagan A; Cai T; Gainer VS; Shaw SY; Churchill S; Karlson EW; Murphy SN; Liao KP; Kohane I
Clin Gastroenterol Hepatol; 2016 Jul; 14(7):973-9. PubMed ID: 26905907
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
Terdiman JP; Steinbuch M; Blumentals WA; Ullman TA; Rubin DT
Inflamm Bowel Dis; 2007 Apr; 13(4):367-71. PubMed ID: 17206695
[TBL] [Abstract][Full Text] [Related]
7. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
8. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
Burr NE; Hull MA; Subramanian V
World J Gastroenterol; 2016 Apr; 22(13):3679-86. PubMed ID: 27053860
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk.
Shadman M; Newcomb PA; Hampton JM; Wernli KJ; Trentham-Dietz A
World J Gastroenterol; 2009 May; 15(19):2336-9. PubMed ID: 19452574
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
van Staa TP; Card T; Logan RF; Leufkens HG
Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
[TBL] [Abstract][Full Text] [Related]
12. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
Vinogradova Y; Hippisley-Cox J; Coupland C; Logan RF
Gastroenterology; 2007 Aug; 133(2):393-402. PubMed ID: 17681160
[TBL] [Abstract][Full Text] [Related]
13. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of statins and risk of colorectal cancer: a population-based study.
Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
Chan EP; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
17. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
[TBL] [Abstract][Full Text] [Related]
18. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
Cheung KS; Chen L; Chan EW; Seto WK; Wong ICK; Leung WK
Aliment Pharmacol Ther; 2020 May; 51(9):899-908. PubMed ID: 32201976
[TBL] [Abstract][Full Text] [Related]
20. Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes.
Hachem C; Morgan R; Johnson M; Kuebeler M; El-Serag H
Am J Gastroenterol; 2009 May; 104(5):1241-8. PubMed ID: 19352344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]